Related Experiment Video
Updated: Aug 9, 2026
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Leptin and atherosclerosis
1Department of Pathophysiology, Medical University, ul. Jaczewskiego 8, 20-090 Lublin, Poland. jerzy.beltowski@am.lublin.pl
Atherosclerosis
|April 4, 2006
Summary
High leptin levels, common in obesity, promote cardiovascular diseases like atherosclerosis. Inhibiting leptin signaling may offer a promising strategy to slow disease progression in affected individuals.
Area of Science:
- Endocrinology
- Cardiovascular Science
- Metabolic Disease
Background:
- Leptin, a hormone from white adipose tissue, regulates energy balance.
- Elevated leptin (hyperleptinemia) is linked to obesity and cardiovascular disease.
- Leptin receptors are present in cardiovascular tissues.
Purpose of the Study:
- To investigate the role of leptin in obesity-associated cardiovascular diseases, particularly atherosclerosis.
- To explore the atherogenic effects of leptin and potential therapeutic strategies.
Main Methods:
- Review of existing studies on leptin's cardiovascular effects.
- Analysis of clinical data correlating leptin levels with cardiovascular events and subclinical atherosclerosis.
- Examination of data from leptin-deficient and receptor-deficient mouse models.
Main Results:
- Leptin promotes atherogenic effects: endothelial dysfunction, inflammation, oxidative stress, and vascular smooth muscle cell proliferation.
- Leptin-deficient mice show protection against arterial injury.
- High leptin levels predict cardiovascular events and correlate with atherosclerosis markers.
Conclusions:
- Hyperleptinemia is a significant contributor to obesity-associated atherosclerosis.
- Inhibiting leptin signaling presents a potential therapeutic target for atherosclerosis in obese individuals.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:38Inflammation
Overview
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...